Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
AHA Journals This Week | June 1, 2020
06/01/2020 | AHA Journals This Week May 26, 2020
Collaboration with LLNL shares COVID-19 research data
05/22/2020 | The American Heart Association is pleased to announced that our collaboration with Lawrence Livermore National Labs (LLNL) on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, the virus that causes COVID-19.
CIRCULATION Editor's Picks | April/May 2020
05/19/2020 | CIRCULATON Editor's Picks for April/May 2020
QCOR 2020 Science News
05/15/2020 | Science News from Quality of Care and Outcomes Research (QCOR) 2020 Scientific Sessions | May, 15-16 2020 | Reston, VA
AHA, ACC redefine guideline processes
04/27/2020 | In a historic move, the AHA and ACC re-visited their 30-year partnership of jointly producing clinical practice guidelines for the cardiovascular community.
STROKE | Trending Topics | March 2020
04/17/2020 | Stroke Trending Topics for March 2020
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.